HK1246651A1 - 珍菇毒蛋白、其功能上相關的變體、包含珍菇毒蛋白的抽提物及其用途 - Google Patents

珍菇毒蛋白、其功能上相關的變體、包含珍菇毒蛋白的抽提物及其用途

Info

Publication number
HK1246651A1
HK1246651A1 HK18106130.8A HK18106130A HK1246651A1 HK 1246651 A1 HK1246651 A1 HK 1246651A1 HK 18106130 A HK18106130 A HK 18106130A HK 1246651 A1 HK1246651 A1 HK 1246651A1
Authority
HK
Hong Kong
Prior art keywords
ostreolysin
extract
functionally related
related variant
variant
Prior art date
Application number
HK18106130.8A
Other languages
English (en)
Inventor
Betty Schwartz
Einav Yehuda-Shnaidman
Lili Nimri
Original Assignee
Yissum Research And Development Company Of The Hebrew Univ Of Jerusalem Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Research And Development Company Of The Hebrew Univ Of Jerusalem Ltd filed Critical Yissum Research And Development Company Of The Hebrew Univ Of Jerusalem Ltd
Publication of HK1246651A1 publication Critical patent/HK1246651A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Child & Adolescent Psychology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Emergency Medicine (AREA)
  • Medical Informatics (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
HK18106130.8A 2014-03-19 2018-05-11 珍菇毒蛋白、其功能上相關的變體、包含珍菇毒蛋白的抽提物及其用途 HK1246651A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461955338P 2014-03-19 2014-03-19
US201461955874P 2014-03-20 2014-03-20
US201462082308P 2014-11-20 2014-11-20

Publications (1)

Publication Number Publication Date
HK1246651A1 true HK1246651A1 (zh) 2018-09-14

Family

ID=53488382

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18106130.8A HK1246651A1 (zh) 2014-03-19 2018-05-11 珍菇毒蛋白、其功能上相關的變體、包含珍菇毒蛋白的抽提物及其用途

Country Status (11)

Country Link
US (3) US10493123B2 (zh)
EP (2) EP3119414B1 (zh)
JP (2) JP2017510635A (zh)
CN (1) CN106232134B (zh)
AU (2) AU2015232974A1 (zh)
CA (2) CA3075791C (zh)
ES (1) ES2746258T3 (zh)
HK (1) HK1246651A1 (zh)
IL (2) IL247838B (zh)
MX (1) MX2016012127A (zh)
WO (1) WO2015140798A2 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3119414B1 (en) 2014-03-19 2019-08-07 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Ostreolysin for use in the treatment of overweight and obesity
US10744070B2 (en) 2015-06-19 2020-08-18 University Of Southern California Enteral fast access tract platform system
CA2990230A1 (en) 2015-06-19 2016-12-22 University Of Southern California Compositions and methods for modified nutrient delivery
KR102429280B1 (ko) * 2020-06-29 2022-08-05 (주)노바셀테크놀로지 신규 교잡품종 버섯의 분말을 유효성분으로 함유하는 비만 예방 및 치료용 약학적 조성물 또는 건강기능성식품

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2911097B2 (ja) 1994-02-25 1999-06-23 カゴメ株式会社 糖タンパク質及びこれを有効成分とする食欲抑制剤
FR2805465B1 (fr) * 2000-02-28 2003-02-21 Medecine Information Formation Nouvelles compositions pharmaceutique ou dietetiques a base de champignons
CA2414912A1 (en) * 2001-12-20 2003-06-20 University Of Saskatchewan Technologies Inc. Pleurotus extract and use in treating hypertension
KR20040057973A (ko) * 2002-12-26 2004-07-02 요시노부 기타지마 플레우로투스 네브로덴시스의 재배방법 및 플레우로투스네브로덴시스를 포함하는 질환 예방 개선제
WO2004096252A1 (en) * 2003-04-25 2004-11-11 Primavera Biosciences, Inc. Compositions and methods for weight loss
JP2006195645A (ja) * 2005-01-12 2006-07-27 Fuji Photo Film Co Ltd データ送受信装置
CN102406686A (zh) * 2007-10-24 2012-04-11 三得利控股株式会社 过氧化物酶体增殖物激活受体（ppar）的配体剂
KR20120132207A (ko) * 2011-05-27 2012-12-05 (주) 해뜰날 버섯균사체쌀 추출물을 포함하는 당뇨병 또는 비만 치료용 약학 조성물
EP3119414B1 (en) * 2014-03-19 2019-08-07 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Ostreolysin for use in the treatment of overweight and obesity

Also Published As

Publication number Publication date
JP6774138B2 (ja) 2020-10-21
CN106232134A (zh) 2016-12-14
US20170368133A1 (en) 2017-12-28
IL267555A (en) 2019-08-29
EP3257520A3 (en) 2018-02-28
WO2015140798A2 (en) 2015-09-24
EP3257520A2 (en) 2017-12-20
AU2015232974A1 (en) 2016-10-06
CA3075791A1 (en) 2015-09-24
CA3075791C (en) 2021-03-30
IL247838A0 (en) 2016-11-30
EP3119414A2 (en) 2017-01-25
CN106232134B (zh) 2019-12-20
MX2016012127A (es) 2017-04-13
JP2017510635A (ja) 2017-04-13
ES2746258T3 (es) 2020-03-05
US10716825B2 (en) 2020-07-21
US20200397848A1 (en) 2020-12-24
US10493123B2 (en) 2019-12-03
EP3119414B1 (en) 2019-08-07
IL267555B (en) 2020-04-30
US20200085905A1 (en) 2020-03-19
EP3257520B1 (en) 2020-01-29
AU2020201858A1 (en) 2020-04-02
CA2943306A1 (en) 2015-09-24
IL247838B (en) 2019-06-30
AU2020201858B2 (en) 2020-05-07
WO2015140798A3 (en) 2016-02-25
JP2020040966A (ja) 2020-03-19

Similar Documents

Publication Publication Date Title
HK1231471A1 (zh) -雜芳氧基-和 芳氧基-喹啉- -甲酰胺及其用途
IL252216B (en) Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines
HK1251183A1 (zh) 生物綴合物及其用途
IL256137B (en) Corneal implant and its use
PL3152226T3 (pl) Modyfikowane cyklopentapeptydy i ich zastosowania
HK1232169A1 (zh) 取代的 -苯基哌啶，其製備和用途
SG11201609490QA (en) Polymer-flavonoid conjugate and uses thereof
GB201408673D0 (en) Medicaments,uses and methods
IL267555B (en) Australolysin, a functionally related variant thereof, an extract containing Australolysin and uses thereof
PL3040062T3 (pl) Struktura chłonna i artykuł chłonny, zawierający tę strukturę chłonną
GB201405784D0 (en) Novel methods, polypeptides and uses thereof
HK1247122A1 (zh) 組合及其用途
PL3166945T3 (pl) Nowe pochodne triazolopirymidynonu lub triazolopirydynonu i ich zastosowanie
IL254241A0 (en) Etv2 and its uses
IL249122A0 (en) History of imidazole- or 4,2,1-triazole and their use
HUE047919T2 (hu) Biológiai asszimilációra alkalmas proteo-melanisztikus komplex, készítmény és felhasználásai
GB201408091D0 (en) Methods and uses
IL249073A0 (en) Cytin-glucan complex, its preparation and uses
GB201416073D0 (en) Methods and uses
GB201416086D0 (en) Methods and uses

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20240314